Ready, Set, Go: Setting Off on the Mission to Target KRAS in Colorectal Cancer
JCO Oncology Practice · 2024-10 · 20 (10) · 1289-1292
DOI: 10.1200/op.24.00295 ↗Kurz gefasst
Editorial in der Zeitschrift JCO Oncology Practice, 2024-10. Verfasst von Andrew J Pellatt und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Mutation, Proto-Oncogene Proteins p21(ras). Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
Understanding the landscape of KRAS mutations in #CRC is crucial with over 2.8M annual diagnoses worldwide. Explore promising therapies and ongoing challenges in this comprehensive review. #CancerResearch #KRAS #ColorectalCancer
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
- Sarah Cannon Research Institute, Nashville, TN.
ORCID-Profile: Andrew J Pellatt, Deepak Bhamidipati, Vivek Subbiah
Zitieren
APA
Pellatt, A. J., Bhamidipati, D., & Subbiah, V. (2024). Ready, Set, Go: Setting Off on the Mission to Target KRAS in Colorectal Cancer. JCO Oncology Practice, 20(10), 1289-1292. https://doi.org/10.1200/op.24.00295
Vancouver
Pellatt AJ, Bhamidipati D, Subbiah V. Ready, Set, Go: Setting Off on the Mission to Target KRAS in Colorectal Cancer. JCO Oncology Practice. 2024;20(10):1289-1292. doi:10.1200/op.24.00295
BibTeX
@article{Pellatt2024,
author = {Pellatt, Andrew J and Bhamidipati, Deepak and Subbiah, Vivek},
title = {Ready, Set, Go: Setting Off on the Mission to Target KRAS in Colorectal Cancer},
journal = {JCO Oncology Practice},
year = {2024},
volume = {20},
number = {10},
pages = {1289--1292},
doi = {10.1200/op.24.00295}
}
EUVIMED